During the past decade, Narayana Hrudayalaya Institute of Medical Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Narayana Hrudayalaya Institute of Medical Sciences" are "Coronary Artery Disease" (1 trials) and "Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Narayana Hrudayalaya Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Narayana Hrudayalaya Institute of Medical Sciences" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Oral treprostinil (UT-15C) Sustained Release Tablets" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Narayana Hrudayalaya Institute of Medical Sciences" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Narayana Hrudayalaya Institute of Medical Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Narayana Hrudayalaya Institute of Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Narayana Hrudayalaya Institute of Medical Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".